Additionally, increased soluble HLA-G levels in del/del patients are associated with impaired NK cell cytotoxicity through its binding to KIR2DL4 ligand expressed by NK cells, as confirmed by in vitro incubation of normal NK cells with plasma samples from CLL patients with variable soluble HLA-G levels. Here, HLA-G is linked to B-cell chronic lymphocytic leukemia.